PPIDT00079
Drug Information
| Name | Antithymocyte immunoglobulin (rabbit) |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB00098 |
| Type | biotech |
| Indication | For prevention of renal transplant rejection |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution, concentrate | Intravenous |
20 MG/ML
|
| Solution | Intravenous |
20 mg/ml
|
| Injection, solution, concentrate | Intravenous |
|
| Injection, solution | Intravenous |
5 ml
|
| Injection, powder, lyophilized, for solution | Intravenous |
5 mg/1mL
|
| Powder, for solution | Intravenous |
25 mg / vial
|
| Powder, for solution | Intravenous |
5 MG/ML
|
| Powder, for solution | Parenteral |
25 MG/5ML
|
| Injection | Intravenous |
5 mg/mL
|
| Injection, powder, lyophilized, for solution | Parenteral |
|
| Injection, powder, lyophilized, for solution | Intravenous |
|
| Injection, powder, for solution | Intravenous |
25 mg
|
| Solution | Intravenous |
25.000 mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
2500000 mg
|
| Powder | — |
5 mg/mL
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | Q95460 | MR1 | Major histocompatibility complex class I-related protein 1 | Homo sapiens | antagonist | Link |
| target | P20701 | ITGAL | Integrin alpha-L | Homo sapiens | inducer | Link |
| target | P42081 | CD86 | T-lymphocyte activation antigen CD86 | Homo sapiens | binder | Link |
| target | P31994 | FCGR2B | Low affinity immunoglobulin gamma Fc region receptor II-b | Homo sapiens | inducer | Link |
| target | P01730 | CD4 | T-cell surface glycoprotein CD4 | Homo sapiens | inducer | Link |
| target | P05556 | ITGB1 | Integrin beta-1 | Homo sapiens | inducer | Link |
| target | P06756 | ITGAV | Integrin alpha-V | Homo sapiens | inducer | Link |
| target | P05106 | ITGB3 | Integrin beta-3 | Homo sapiens | inducer | Link |
| target | P06126 | CD1A | T-cell surface glycoprotein CD1a | Homo sapiens | inhibitor | Link |